MedPath

Effect of fibrinogen on bleeding during pelvic surgery

Phase 3
Recruiting
Conditions
Pelvic Surgery.
Multiple fractures of lumbar spine and pelvis
S32.7
Registration Number
IRCT20200109046064N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
42
Inclusion Criteria

Patients candidate for non-emergency pelvic surgery undergoing general anesthesia
Satisfaction with study participation
Age between 18-60
BMI<30
The preoperative fibrinogen level should be 2-4 g/lit

Exclusion Criteria

cardiovascular, liver, kidney, coagulation and hypertension disorders, diabetes and tumors in surgical areas.
History of use the Beta-Blocker, Calcium Blocker, Digoxin, Tricyclic Antidepressants, Anti-Coagulant and Clonidine
A history of alcohol, drug and drug abuse

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Plasma fibrinogen. Timepoint: Before and after surgery. Method of measurement: Based on the patient's blood laboratory results.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath